Search alternatives:
treated decrease » greater decrease (Expand Search), greatest decrease (Expand Search), treatment decreased (Expand Search)
marked decrease » marked increase (Expand Search)
sub treated » hu treated (Expand Search), b treated (Expand Search), sand treated (Expand Search)
treated decrease » greater decrease (Expand Search), greatest decrease (Expand Search), treatment decreased (Expand Search)
marked decrease » marked increase (Expand Search)
sub treated » hu treated (Expand Search), b treated (Expand Search), sand treated (Expand Search)
-
1
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
2
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
3
-
4
Effects of CER on vascular calcification and phenotypic change in P<sub>i</sub><i>‐</i>treated VSMCs.
Published 2025“…Bar graphs depicted significant decrease in mRNA expression of (C) α -SMA (D) SM22α and increased (E) RUNX2 (F) OPN and (G) BMP2 in CER treated P<sub>i</sub>-induced VSMCs. …”
-
5
-
6
Effect of Gasdermin-D inhibition on CER-induced pyroptosis in P<sub>i</sub><i>‐</i>treated VSMCs.
Published 2025“…<p>Summarized bar graphs showed DIS significantly decreased mRNA expression of pyroptotic markers (A) NLRP3 (B) GSDM-D, proinflammatory cytokines (C) IL-1β (D) IL-18, and (E) Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
7
Effect of NLRP3 inhibition on CER-induced pyroptosis in P<sub>i</sub><i>‐</i>treated VSMCs.
Published 2025“…<p>Summarized bar graphs showed MCC950 significantly decreased mRNA expression of pyroptotic markers (A) NLRP3 (B) GSDM-D, proinflammatory cytokines (C) IL-1β (D) IL-18, and (E) Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
8
-
9
-
10
-
11
Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients.
Published 2025“…This decrease was larger in the disconnected than in the contralateral cortex. …”
-
12
-
13
Biases in larger populations.
Published 2025“…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …”
-
14
-
15
-
16
-
17
The XRD patterns of treated specimens.
Published 2025“…Increased numbers of freeze-thaw cycles exacerbated damage to the cementation network. Saline soils with Na<sub>2</sub>SO<sub>4</sub> ≥ 6% exhibited markedly reduced resistance to degradation: porosity-reduction magnitude fell to 12.27% and cohesion decreased to 0.057 MPa. …”
-
18
-
19
Effect of Gasdermin-D inhibition on expression of phenotypic transition markers in CER treated VSMCs during Vascular Calcification.
Published 2025“…(B) Summarized bar graph showed DIS significantly decreased calcium deposition in CER treated P<sub>i</sub>-induced VSMCs. …”
-
20
Effect of NLRP3 inhibition on expression of phenotypic transition markers in CER treated VSMCs during Vascular Calcification.
Published 2025“…(B) Summarized bar graph showed MCC950 significantly decreased calcium deposition in CER treated P<sub>i</sub>-induced VSMCs. …”